Immunovia AB (publ) announced appointment of Nomination Committee for the 2023 Annual General Meeting . Based on the above, the Nomination Committee for the 2023 Annual General Meeting has been determined to consist of the following persons who together represent 13.46% of the number of shares and votes in the company as of September 30, 2022: Ranny Davidoff, representing Ranny Davidoff Carl Borrebaeck, Chairman of the Board, Peter Lindvall representing Mikael Löfman; and Mats Leifland, representing Mats Ohlin.